Skip to main content

Table 1 Strain details from growth characterizations

From: Reframing gene essentiality in terms of adaptive flexibility

Keio strain

Possible alternate

Final cell density (gDW/L)

Time to > half

Mutations

 

genes/pathways

*mean, Std. Dev., %RSD

final density (Hrs)

flask1

   

*mean, Std. Dev., %RSD

population?

WT glucose

-

1.0, <0.01, 0.2%

10, <1, <0.01%

No

WT glycerol

-

1.1, 0.04, 3%

12, <1, 0.04%

No

Δ ubiE

Alternate growth using

0.43, 0.08, 20%

14, 1, 9%

No

 

demethylmenaquinone1

   

Δ cysK

cysM 2

1.0, 0.1, 10%

21, <1, <0.01%

Variable

Δ metL

(thrA or lysC)2

1.0, 0.1, 9%

28, 2, 7%

Variable

Δ metC

(tnaA or malY)2,

0.28, 0.1, 50%

36, 9, 20%

Variable

 

(malY, alr, fimE)3

   

Δ thrA

(metL or lysC)2

1.1, 0.1, 8%

43, <1, 0.04%

Yes

Δ carA

(yahI or arcC or yqeA)2,

0.50, 0.2, 40%

58, 17, 30%

Variable

 

(carB, ygiT, cho, yncK)3

   

Δ cysP

(modA + modB + modC)2

1.1, 0.1, 10%

65, <1, 0.2%

No

Δ proA

argE 2

1.1, 0.3, 20%

190, 26, 10%

Yes

Δ proB

argE 2

0.66, 0.3, 50%

83, 10, 10%

Yes

Δ ptsI

galP2, (fucP, xylE, galE)3

1.1, 0.1, 10%

100, 5, 5%

Yes

Δ serB

glyA2, (gph, hisB, ytjC)3

0.95, 0.2, 20%

110, 8, 7%

Yes

  1. 1Evidence for this described in [64]. 2In silico prediction, iJO1366 genome-scale model of metabolism [13]. 3Experimental multicopy suppression evidence [19]. *The data used from triplicate experiments represented in Fig. 1b was used to calculate means, standard deviations (St. Dev.), and percent relative standard deviations (%RSD)